VBIV - VBI Vaccines GAAP EPS of -$5.05 misses by $2.89 revenue of $0.74M misses by $0.19M August, 14 2023 09:01 AM VBI Vaccines Inc. 2023-08-14 09:01:49 ET VBI Vaccines press release ( NASDAQ: VBIV ): Q2 GAAP EPS of -$5.05 misses by $2.89 . Revenue of $0.74M (+111.4% Y/Y) misses by $0.19M . For further details see: VBI Vaccines GAAP EPS of -$5.05 misses by $2.89, revenue of $0.74M misses by $0.19M